BME (Blackrock Health Sciences Trust) ROC (Joel Greenblatt) %: % (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BME Blackrock Health Sciences Trust BME
39 GF Score
Price $45.80
! 4 Warning Signs
View Full Analysis

What is Blackrock Health Sciences Trust ROC (Joel Greenblatt) %?

Blackrock Health Sciences Trust BME +0.37% 39 ROC (Joel Greenblatt) % is % as of Dec. 2025. GuruFocus rates BME with a GF Score™ of 39/100. The stock has 4 warning signs investors should review. Among 631 Asset Management companies, Blackrock Health Sciences Trust ranks worse than 158478.45% on this metric.

ROC (Joel Greenblatt) % does not apply to banks and insurance companies.

BME
39GF Score
Blackrock Health Sciences Trust BME
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a ROC (Joel Greenblatt) % of % mean?
Blackrock Health Sciences Trust (BME) has a ROC (Joel Greenblatt) % of % as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Blackrock Health Sciences Trust and its competitors. According to the industry distribution chart, Blackrock Health Sciences Trust ranks #999999 out of 631 companies in the Asset Management industry.
Is Blackrock Health Sciences Trust's ROC (Joel Greenblatt) % too high?
Blackrock Health Sciences Trust's current ROC (Joel Greenblatt) % is %. Based on the distribution chart, Blackrock Health Sciences Trust ranks #999999 out of 631 companies in the Asset Management industry, which is in the bottom quartile relative to peers. Overall, Blackrock Health Sciences Trust has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Blackrock Health Sciences Trust's ROC (Joel Greenblatt) % compare to MMU and ETJ?
According to the Asset Management industry distribution chart, Blackrock Health Sciences Trust ranks #999999 out of 631 companies for ROC (Joel Greenblatt) %. This places Blackrock Health Sciences Trust in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 64.71. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for an Asset Management company?
The median ROC (Joel Greenblatt) % among Asset Management companies is 64.71, based on 631 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Blackrock Health Sciences Trust and its competitors. For the Asset Management industry, the median ROC (Joel Greenblatt) % is 64.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Blackrock Health Sciences Trust's current ROC (Joel Greenblatt) % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blackrock Health Sciences Trust stock overvalued right now?
Blackrock Health Sciences Trust (BME) has a current ROC (Joel Greenblatt) % of %. The current ROC (Joel Greenblatt) % is %. Blackrock Health Sciences Trust's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Blackrock Health Sciences Trust (BME), the current ROC (Joel Greenblatt) % is % as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Blackrock Health Sciences Trust Business Description

Address 100 Bellevue Parkway, Wilmington, DE, USA, 19809
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.
39GF Score

Get the complete analysis for BME

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$45.80
Price